Neostigmine
Active pharmaceutical substance formulated in Jan Aushadhi generic products for CNS, Nerve & Mental Health treatment.
🧴 Clinical Application
Administered by anesthesiologists or intensive care physicians by slow intravenous injection, always preceded or accompanied by an anticholinergic agent (atropine or glycopyrrolate) to prevent severe muscarinic bradycardia and bronchospasm. Continuous monitoring of heart rate and respiration is mandatory.
⚠️ Side Effects
Common: Excessive salivation, nausea, diarrhea, abdominal cramps, sweating, muscle fasciculations. Rare/Severe: Severe bradycardia, heart block, cardiac arrest, cholinergic crisis, and severe bronchospasm.
🛡️ Safety Warnings
Must always be co-administered with atropine or glycopyrrolate to counteract potentially fatal muscarinic bradycardia and asystole. Contraindicated in mechanical intestinal or urinary obstruction and peritonitis. Resuscitation equipment must be present.
Jan Aushadhi Products containing Neostigmine
Found 2 generic formulation(s) containing this active ingredient.
Neostigmine Methylsulphate Injection 0.5mg/ml
Neostigmine Methylsulphate is a synthetic quaternary ammonium reversible anticholinesterase agent on the WHO Model List of Essential Medicines. It inhibits acetylcholinesterase at the neuromuscular junction and postganglionic parasympathetic synapses, accumulating acetylcholine and competitively displacing non-depolarizing muscle relaxants. Indicated parenterally for the reversal of non-depolarizing neuromuscular blockade post-surgery, myasthenia gravis crisis, and non-obstructive postoperative paralytic ileus/urinary retention.
Neostigmine Methylsulphate Injection 2.5mg/ml
Neostigmine Methylsulphate is a synthetic quaternary ammonium reversible anticholinesterase agent on the WHO Model List of Essential Medicines. It inhibits acetylcholinesterase at the neuromuscular junction and postganglionic parasympathetic synapses, accumulating acetylcholine and competitively displacing non-depolarizing muscle relaxants. Indicated parenterally for the reversal of non-depolarizing neuromuscular blockade post-surgery, myasthenia gravis crisis, and non-obstructive postoperative paralytic ileus/urinary retention.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Neostigmine.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Neostigmine Methylsulphate Injection 0.5mg/ml | 5ml Ampoule | ₹13.13 | MYOSTIGMIN, Myostigmin, Neotagmin, NOVELTREAT, WEGOVY | ₹9080.57 | 100% Save |
| Neostigmine Methylsulphate Injection 2.5mg/ml | 1ml Ampoule | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Neostigmine generics.